Topics

Vical Inc VICL Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

22:46 EDT 2 Oct 2019 | BioPortfolio Reports

Vical Inc VICL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including:


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Highlights


Vical Inc Vical is a biopharmaceutical company focuses on the development of products for the prevention and treatment of lifethreatening or chronic infectious diseases including fungal and viral infections. Its has proprietary core DNA delivery technology which is based on plasmid DNA pDNA in which closed loops of DNA are encoded with protein of interest. The company's other proprietary technology platform includes Vaxfectin adjuvant which is a cationic lipidbased formulation to improve protein based vaccines and plasmid DNAbased vaccines. Vical is headquartered in San Diego, California, the US.


Vical Inc Key Recent Developments


Feb 19,2019: Vical announces fourth quarter 2018 financial and operating results

Oct 29,2018: Vical announces third quarter 2018 financial results

Aug 07,2018: Vical reports second quarter 2018 financial and operational results

May 03,2018: Vical Reports First Quarter 2018 Financial and Operational Results

Mar 15,2018: Vical Reports Fourth Quarter 2017 Financial and Operational Results


Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Note: Some sections may be missing if data is unavailable for the company

Original Article: Vical Inc VICL Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Vical Inc VICL Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125"

Quick Search

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...